Related Experiment Video
Updated: Apr 13, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
Published on: June 7, 2018
[Chemotherapy-induced cardiotoxicity: Incidence, diagnosis and prevention]
Marie Nelson-Veniard1, Jean-Benoit Thambo1
1Hôpital cardiologique du Haut Lévêque, service des cardiopathies congénitales de l'enfant et de l'adulte, Bordeaux-Pessac, France.
Abstract:
Chemotherapy-induced cardiotoxicity is a major cause of morbidity and mortality in cancer survivor. The most clinically evident and best known cardiotoxicity is the anthracycline adverse effect with heart failure. Many cardiovascular adverse effects appear after cancer therapy: heart congestive failure, myocardial ischemia, hypertension, thromboembolic complications, arrhythmias and conduction disturbances. There are potential strategies to mitigate the risks of cardiac complications for cancer patients with physical examination, echocardiography and electrocardiogram. The management of the cardiotoxicity is variable.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiac Catheterization I: Pre-Procedure Overview
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy IV: Restrictive Cardiomyopathy

